DJIA 17,698.18 -77.94 -0.44%
NASDAQ 4,880.23 -20.66 -0.42%
S&P 500 2,059.69 -8.20 -0.40%
market minute promo

Allergan, Inc. (NYSE: AGN)



company name or ticker
Company Photos
(Click to zoom)

Pershing Square Holdings: First Annual Report

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?

Merger Arbitrage Mondays - March 23, 2015

Why Pfizer Inc. Isn't Built to Last

Pfizer may be about to break up. Here's what investors need to know.

This Exciting Biotech Isn't Built to Last

Acadia Pharmaceuticals' Parkinson's disease drug was guaranteed a speedy review and the attention of top FDA officials. So why did this company's stock recently tank so rapidly? There's a cautionary tale here for all biotech investors.

The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Salix Pharmaceuticals, End

The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Salix Pharmaceuticals, Endo International and Allergan - Press Releases

Actavis' Depression Drug Gains FDA Approval for New Dose - Analyst Blog

Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog

Commodities Today: More Bearish Calls For Oil And Precious Metals, Airlines Rally On Lower Oil Price

Commodities Today: More Bearish Calls For Oil And Precious Metals, Airlines Rally On Lower Oil Prices

Actavis Has More Upside With Allergan Acquisition Says Cramer

See More Articles...